Shoji Tokunaga Selected Research

Biological Products

8/2007	Body mass index and oxidative DNA damage: a longitudinal study.
3/2006	Leanness, smoking, and enhanced oxidative DNA damage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shoji Tokunaga Research Topics

Disease

14	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 02/2008
10	Neoplasms (Cancer) 12/2020 - 03/2006
7	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 01/2011
5	Neoplasm Metastasis (Metastasis) 01/2020 - 09/2013
4	Overactive Urinary Bladder (Overactive Bladder) 01/2021 - 01/2017
4	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2021 - 05/2007
4	Colonic Neoplasms (Colon Cancer) 06/2020 - 01/2003
4	Lung Neoplasms (Lung Cancer) 01/2016 - 03/2006
3	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 02/2010
3	Carcinogenesis 08/2007 - 01/2003
2	Thrombocytopenia (Thrombopenia) 01/2020 - 10/2019
2	Hypertension (High Blood Pressure) 02/2019 - 02/2016
2	Carcinoma (Carcinomatosis) 01/2016 - 02/2010
2	Neutropenia 04/2013 - 04/2010
2	Fever (Fevers) 02/2012 - 04/2010
2	Foodborne Diseases 04/2011 - 01/2011
1	Esophageal Squamous Cell Carcinoma 01/2022
1	Lower Urinary Tract Symptoms 01/2020
1	Pain (Aches) 01/2020
1	Hyperlipidemias (Hyperlipidemia) 02/2019
1	Body Weight (Weight, Body) 11/2018
1	Stomach Neoplasms (Stomach Cancer) 01/2018
1	Pancreatic Diseases (Pancreatic Disease) 11/2017
1	Drug-Related Side Effects and Adverse Reactions 01/2017
1	Thrombosis (Thrombus) 02/2016
1	Disease Progression 02/2016
1	Neoplasms, Cystic, Mucinous, and Serous 01/2016
1	Solitary Fibrous Tumors 03/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2013
1	Pancreatitis 07/2013
1	Adenocarcinoma 07/2013
1	Yusho Disease 02/2013
1	Seasonal Allergic Rhinitis (Hay Fever) 01/2013
1	Atopic Dermatitis (Atopic Eczema) 05/2012
1	Pruritus (Itching) 05/2012

Drug/Important Bio-Agent (IBA)

7	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2020 - 01/2011
6	Fluorouracil (Carac)FDA LinkGeneric 06/2020 - 02/2010
6	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 02/2008
4	Bevacizumab (Avastin)FDA Link 01/2018 - 11/2014
4	Leucovorin (Folinic Acid)FDA Link 12/2016 - 01/2011
3	Tamsulosin (Flomax)FDA LinkGeneric 01/2021 - 01/2017
3	Dutasteride (Avodart)FDA Link 01/2021 - 01/2017
3	imidafenacinIBA 01/2021 - 01/2017
3	Gemcitabine FDA Link 01/2020 - 10/2019
3	Paclitaxel (Taxol)FDA LinkGeneric 11/2019 - 02/2008
3	Dietary Fiber FDA Link 01/2005 - 12/2002
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2016
2	Cisplatin (Platino)FDA LinkGeneric 03/2021 - 01/2018
2	Vinorelbine (Navelbine)FDA LinkGeneric 03/2021 - 12/2013
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2020 - 03/2011
2	alectinibIBA 01/2020 - 01/2017
2	Capecitabine (Xeloda)FDA Link 06/2017 - 04/2013
2	Irinotecan (Camptosar)FDA LinkGeneric 12/2016 - 02/2016
2	Cetuximab (Erbitux)FDA Link 12/2015 - 12/2015
2	Proteins (Proteins, Gene)FDA Link 09/2013 - 01/2003
2	BilirubinIBA 04/2013 - 04/2010
2	Polychlorinated Biphenyls (PCBs)IBA 02/2013 - 05/2008
2	DioxinsIBA 02/2013 - 01/2011
2	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2012 - 02/2008
2	Biological ProductsIBA 08/2007 - 03/2006
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2005 - 01/2003
1	PlatinumIBA 03/2021
1	UracilIBA 12/2020
1	TegafurIBA 12/2020
1	Tadalafil (Cialis)FDA Link 01/2020
1	mirabegronIBA 01/2020
1	Enzyme Precursors (Zymogens)IBA 01/2020
1	Docetaxel (Taxotere)FDA Link 12/2019
1	Telmisartan (Micardis)FDA Link 02/2019
1	Angiotensin IIIBA 02/2019
1	candesartanIBA 02/2019
1	Glucose (Dextrose)FDA LinkGeneric 02/2019
1	Gefitinib (Iressa)FDA Link 01/2019
1	Fentanyl (Sublimaze)FDA LinkGeneric 11/2018
1	Propofol (Diprivan)FDA LinkGeneric 11/2018
1	4-azidosalicylic acid-phosphatidylserineIBA 11/2018
1	Carcinoembryonic AntigenIBA 11/2017
1	Blood Proteins (Serum Proteins)IBA 12/2016
1	Circulating Tumor DNAIBA 12/2016
1	Panitumumab (Vectibix)FDA Link 12/2016
1	Epidermal Growth Factor (EGF)IBA 01/2016
1	SmokeIBA 01/2016
1	Indicators and Reagents (Reagents)IBA 09/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2014
1	Formaldehyde (Formol)FDA Link 09/2013
1	ParaffinIBA 09/2013
1	MucinsIBA 07/2013
1	urinastatin (MR 20)IBA 07/2013
1	levocetirizine FDA LinkGeneric 01/2013
1	Nasal SpraysIBA 01/2013
1	fluticasone furoate FDA Link 01/2013
1	Tacrolimus (Prograf)FDA LinkGeneric 05/2012

Therapy/Procedure

17	Therapeutics 01/2022 - 02/2008
8	Adjuvant Chemotherapy 05/2022 - 02/2008
5	Drug Therapy (Chemotherapy) 01/2020 - 04/2010
3	Combination Drug Therapy (Combination Chemotherapy) 02/2016 - 01/2011
2	Radiotherapy 01/2019 - 12/2013
1	Radiofrequency Ablation 07/2016
1	Pancreatectomy 01/2016
1	Chemoradiotherapy 12/2013